BIOT.L vs. AUCO.L
BIOT.L (L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF) and AUCO.L (L&G Gold Mining UCITS ETF) are both exchange-traded funds - BIOT.L is a Health & Biotech Equities fund tracking the Solactive Pharma Breakthrough Value Index Net Total Return, while AUCO.L is a Gold fund tracking the STOXX Global Gold Miners Index. Both are passively managed. Over the past 5 years, BIOT.L returned 2.83%/yr vs 22.07%/yr for AUCO.L. At a 0.25 correlation, their price movements are largely independent. BIOT.L charges 0.49%/yr vs 0.55%/yr for AUCO.L.
Performance
BIOT.L vs. AUCO.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIOT.L achieves a 8.27% return, which is significantly higher than AUCO.L's -14.70% return.
BIOT.L
- 1D
- 0.31%
- 1M
- 7.79%
- 6M
- 7.56%
- YTD
- 8.27%
- 1Y
- 33.81%
- 3Y*
- 10.20%
- 5Y*
- 2.83%
- 10Y*
- —
AUCO.L
- 1D
- -2.98%
- 1M
- -14.48%
- 6M
- -23.42%
- YTD
- -14.70%
- 1Y
- 48.05%
- 3Y*
- 41.28%
- 5Y*
- 22.07%
- 10Y*
- 11.99%
BIOT.L vs. AUCO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF | 8.27% | 36.47% | -5.31% | -9.28% | -8.41% | -3.60% | 28.29% | 13.02% | -8.12% |
AUCO.L L&G Gold Mining UCITS ETF | -14.70% | 181.83% | 17.96% | 15.02% | -14.30% | -10.12% | 21.72% | 44.14% | -14.07% |
Correlation
The correlation between BIOT.L and AUCO.L is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jan 18, 2018 | 0.25 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIOT.L vs. AUCO.L — Risk / Return Rank
BIOT.L
AUCO.L
BIOT.L vs. AUCO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) and L&G Gold Mining UCITS ETF (AUCO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIOT.L | AUCO.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.69 | ||
| Sortino ratioReturn per unit of downside risk | +0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.18 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 3.52 | 1.27 | +2.25 |
| Martin ratioReturn relative to average drawdown | 10.12 | 2.97 | +7.15 |
Loading charts...
Drawdowns
BIOT.L vs. AUCO.L - Drawdown Comparison
The maximum BIOT.L drawdown since its inception was -34.44%, smaller than the maximum AUCO.L drawdown of -78.30%. Use the drawdown chart below to compare losses from any high point for BIOT.L and AUCO.L.
Loading charts...
Drawdown Indicators
| BIOT.L | AUCO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.44% | -78.30% | +43.86% |
Max Drawdown (1Y)Largest decline over 1 year | -9.55% | -37.60% | +28.05% |
Max Drawdown (3Y)Largest decline over 3 years | -19.91% | -37.60% | +17.69% |
Max Drawdown (5Y)Largest decline over 5 years | -33.80% | -48.62% | +14.82% |
Max Drawdown (10Y)Largest decline over 10 years | — | -54.47% | — |
Current DrawdownCurrent decline from peak | -5.72% | -36.38% | +30.66% |
Average DrawdownAverage peak-to-trough decline | -13.31% | -40.73% | +27.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.33% | 16.11% | -12.78% |
Volatility
BIOT.L vs. AUCO.L - Volatility Comparison
The current volatility for L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) is 6.08%, while L&G Gold Mining UCITS ETF (AUCO.L) has a volatility of 16.05%. This indicates that BIOT.L experiences smaller price fluctuations and is considered to be less risky than AUCO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIOT.L | AUCO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.08% | 16.05% | -9.97% |
Volatility (6M)Calculated over the trailing 6-month period | 15.54% | 39.39% | -23.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.18% | 48.92% | -28.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.62% | 38.99% | -20.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.50% | 35.75% | -16.25% |
BIOT.L vs. AUCO.L - Expense Ratio Comparison
BIOT.L has a 0.49% expense ratio, which is lower than AUCO.L's 0.55% expense ratio.
Dividends
BIOT.L vs. AUCO.L - Dividend Comparison
Neither BIOT.L nor AUCO.L has paid dividends to shareholders.
Frequently Asked Questions
BIOT.L and AUCO.L have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BIOT.L is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BIOT.L is cheaper with a 0.49% expense ratio, compared with 0.55% for AUCO.L.
BIOT.L is categorized as Health & Biotech Equities, while AUCO.L is Gold. BIOT.L tracks Solactive Pharma Breakthrough Value Index Net Total Return, while AUCO.L tracks STOXX Global Gold Miners Index. Their fees differ too: 0.49% for BIOT.L and 0.55% for AUCO.L.
Find the right allocation for BIOT.L and AUCO.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer